Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.4
3.9
Journals
JCM
Special Issues
Clinical Advances in Transcatheter Aortic Valve Replacement
share announcement

Clinical Advances in Transcatheter Aortic Valve Replacement

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 5 September 2024 | Viewed by 409

Special Issue Editor

Dr. Gry Dahle

E-Mail Website
Guest Editor
Department of Cardiothoracic surgery, Oslo University Hospital, 0372 Oslo, Norway
Interests: transcatheter therapies; mini-invasive surgery; innovations; implementing new methods and ethics

Special Issue Information

Dear Colleagues,

It has now been 22 years since the first transcatheter aortic valve implantation (TAVI) implant. The indications have moved from high-risk to low-risk, as have younger patients. There has been a huge evolution in valve development and delivery systems, imaging, and procedural strategy. Still, we have the issue of durability: “Who lives longer, the valve or the patient”? With TAVI in younger patients, bicuspid valves and aortic regurgitation have to be addressed. The explant of a TAVI valve may be hazardous, but it is an increasing trend in the US.

These topics will be discussed by the opinion leaders in this Special Issue.

Dr. Gry Dahle
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • how far can we expand TAVI to SAVR
  • the increasing number and results of TAVI explants
  • TAVI in bicuspid valves
  • TAVI solutions for aortic regurgitation
  • TAVI in low risk vs. younger patients
  • the role of artificial intelligence for TAVI planning
  • peri procedural care for TAVI patients

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

12 pages, 2093 KiB  
Review
Transcatheter Aortic Valve Implantation for Severe Chronic Aortic Regurgitation
by Judy Al Ahmad and Edward Danson
J. Clin. Med. 2024, 13(10), 2997; https://doi.org/10.3390/jcm13102997 - 20 May 2024
Viewed by 221
Abstract
Transcatheter aortic valve implantation (TAVI) has revolutionised the management of aortic valve disease, offering a less invasive alternative to traditional surgical valve replacement for severe aortic stenosis (AS). TAVI for pure aortic regurgitation (AR) is less well established, and, in fact, it was [...] Read more.
Transcatheter aortic valve implantation (TAVI) has revolutionised the management of aortic valve disease, offering a less invasive alternative to traditional surgical valve replacement for severe aortic stenosis (AS). TAVI for pure aortic regurgitation (AR) is less well established, and, in fact, it was previously labelled as a relative contraindication. However, TAVI has been utilised for selected cases of pure or predominant AR. The primary limitations regarding the use of TAVI in AR are related to the absence of anatomical factors seen in patients with AS that have contributed to the safe and stable functioning of current-generation prostheses. These include aortic root dilatation, mobile valve leaflets and labile blood pressure within the aortic root, which may further increase the risk of valve migration and periprosthetic leak after deployment. Furthermore, patients with AR have more heterogeneous aortic root anatomies when compared to the population of patients with calcific or degenerative AS. This review article describes the current evidence for the off-label use of TAVI in pure AR and the various clinical syndromes associated with AR where there may be specific challenges in the application of TAVI. Full article
(This article belongs to the Special Issue Clinical Advances in Transcatheter Aortic Valve Replacement)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop